Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/25/2026

1. INTC
2. DECK
3. AMD
4. META
5. INFY
6. RNG
7. TMUS
8. SPY
9. UNP
10. GOOGL

Go back to Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion
(NASDAQ: AURA) Delayed: 7.05 -0.15 (2.08%)
Previous Close $7.20    52 Week High $ 
Open $7.11    52 Week Low $ 
Day High $7.23    P/E N/A 
Day Low $6.99    EPS $ 
Volume 325,838